A Phase II, prospective, double-blinded, randomized controlled trial of AmnioFix injectable in the treatment of knee osteoarthritis.

Trial Profile

A Phase II, prospective, double-blinded, randomized controlled trial of AmnioFix injectable in the treatment of knee osteoarthritis.

Planning
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2017

At a glance

  • Drugs DHACM (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Oct 2017 According to a MiMedx media release, the company has been notified by the Food and Drug Administration (FDA) that its Investigational New Drug (IND) Phase 2B clinical study for osteoarthritis of the knee may proceed and the company expects patient enrollment to commence in the next quarter.
    • 21 Sep 2017 New trial record
    • 19 Sep 2017 According to a MiMedx media release, company has filed with the Food and Drug Administration (FDA) to initiate its Investigational New Drug (IND) Phase 2 clinical trial and expects patient enrollment to commence by the end of the year.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top